SCHEMBL6559720

SCHEMBL6559720

COc1nc(C)c(C)nc1NC(=O)N1CCN(c2ccsc2C)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.39
RAB9A P51151 1/20 0.39
HTR1A P08908 5/20 0.39
HTR1D P28221 5/20 0.39
HTR1B P28222 5/20 0.39
ALDH1A1 P00352 4/20 0.39
GAA P10253 2/20 0.39
KDM4E B2RXH2 2/20 0.39
HPGD P15428 2/20 0.39
CASP1 P29466 2/20 0.39
HSD17B10 Q99714 2/20 0.39
ATM Q13315 1/20 0.39
FAAH O00519 4/20 0.39
MAPK1 P28482 3/20 0.39
LMNA P02545 2/20 0.39
TSHR P16473 1/20 0.39
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
HTR7 P34969 1/20 0.39
HTR6 P50406 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6560843 0.89 MAPT (0.42) MAPTRAB9AHTR1AHTR1DHTR1B
SCHEMBL6560562 0.87 LMNA (0.42) MAPTALDH1A1ATMLMNASMN1; SMN2
SCHEMBL6965274 0.84 PI4KB (0.41) MAPTRAB9AHTR1AHTR1DHTR1B
SCHEMBL7804724 0.82 PDGFRB (0.39) MAPTRAB9AHTR1AHTR1DHTR1B
SCHEMBL6954299 0.82 RBP4 (0.41) MAPTRAB9AHTR1AHTR1DHTR1B
SCHEMBL6560608 0.81 MAPT (0.60) MAPTRAB9AHTR1AHTR1DHTR1B
SCHEMBL6560465 0.80 MAPT (0.46) MAPTRAB9AHTR1AHTR1DHTR1B
SCHEMBL6559632 0.80 KMT2A (0.60) MAPTRAB9AHTR1AHTR1DHTR1B
SCHEMBL6561018 0.80 RBP4 (0.52) MAPTHTR1AHTR1DHTR1BALDH1A1
SCHEMBL6559625 0.79 MAPT (0.44) MAPTRAB9AHTR1AHTR1DHTR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1075469-B1 PIPERAZINE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF SAMJIN PHARM CO LTD (KR) 2004-05-26 EP disclosed
US-6683184-B2 ANTITUMOR AGENTS SAMJIN PHARMACEUTICAL CO., LTD. (KR) 2004-01-27 US disclosed
US-20030092910-A1 Piperazine derivatives and process for the preparation thereof SAMJIN PHARMACEUTICAL CO., LTD. (KR) 2003-05-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030092910-A1 Piperazine derivatives and process for the preparation thereof CBR1, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, HCCS MAPT 4877/4885RAB9A 2925/4885HTR1A 1259/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.